Urologix (ULGX) Closes 5.2M Offering, Full-Allotment Exercised

Urologix, Inc. (Nasdaq: ULGX), announced the sale of an additional 780,000 shares of its common stock at a price to the public of $0.75 per share. The sale was pursuant to a 45-day over-allotment option granted to the underwriter as part of the Company's recently completed public offering of 5,200,000 shares of its common stock that closed July 5, 2012. Urologix received proceeds of approximately $544,000, after underwriter discounts, from the sale of the over-allotment shares.

Dougherty & Company LLC served as the sole underwriter for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Treasure Global sells shares in two deals worth $6.6M total
• CBAK Energy expands Nanjing battery cell capacity toward 18 GWh
• Azio AI Holdings names South Texas compute campus Atlas One